Even before his son was born, Pawan Sinha saw unique potential.
At a birthing class, Dr. Sinha, a neuroscience professor at the Massachusetts Institute of Technology, stunned everyone, including his wife, by saying he was excited about the baby’s birth “because I really want to study him and do experiments with him.” He did, too, strapping a camera on baby Darius’s head, recording what he looked at.
Dr. Sinha is among a new crop of scientists using their children as research subjects.
Other researchers have studied their own children in the past, but sophisticated technology allows modern-day scientists to collect new and more detailed data. The scientists also say that studying their children allows for more in-depth research and that the children make reliable participants in an era of scarce research financing.
Quoted from http://www.fiercebiotech.com/story/fda-staffers-endorse-gtcs-transgenic-anti-clotting-drug/2009-01-07?utm_medium=nl&utm_source=internal&cmp-id=EMC-NL-FB&dest=FB:
The field of transgenics--developing therapies in genetically engineered animals--just got a big boost from staffers at the FDA. Regulators said that Framingham, MA-based GTC BioTherapeutics's drug ATryn, an anti-clotting treatment produced in goats, appeared to be safe and effective. The recommendation was released in documents made available ahead of an expert advisory committee meeting on Friday.
...GTC is one of a handful of companies out to demonstrate that it can produce a less-expensive stream of therapeutics from transgenic animals, harvesting drugs through their milk.
About:
"The American Committee for the Weizmann Institute of Science (ACWIS), founded in 1944, develops philanthropic support for the Weizmann Institute of Science in Israel, one of the world's premier scientific research institutions. The Weizmann Institute is a center of basic interdisciplinary scientific research and graduate study, addressing crucial problems in technology, medicine and health, energy, agriculture and the environment."